Skip to main content
Back
ALHC logo

Alignment Healthcare, Inc.

Data quality: 100%
ALHC
NASDAQ Healthcare Medical - Healthcare Plans
$17.51
▲ $0.17 (0.98%)
Mkt Cap: 3.58B
Day Range
$17.07 $17.81
52-Week Range
$11.63 $23.87
Volume
3,428,907
50D / 200D Avg
$20.42 / $17.32
Prev Close
$17.34

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E -4940.9 0.4
P/B 20.0 2.9
ROE % -0.5 3.7
Net Margin % 0.0 3.8
Rev Growth 5Y % 35.6 10.0
D/E 1.9 0.2

Key Takeaways

Revenue grew 35.60% annually over 5 years — strong growth
Generating 113.15M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 10.46%
Capital efficient — spends only 0.68% of revenue on capex
ROIC of 2.14% — low return on invested capital
Interest coverage of 0.93× — tight debt servicing

Growth

Revenue Growth (5Y)
35.60%
Revenue (1Y)46.06%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-0.52%
ROIC2.14%
Net Margin-0.02%
Op. Margin0.37%

Safety

Debt / Equity
1.89
Current Ratio1.74
Interest Coverage0.93

Valuation

P/E Ratio
-4940.93
P/B Ratio19.95
EV/EBITDA226.23
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 46.06% Revenue Growth (3Y) 47.15%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 35.60% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3.95B Net Income (TTM) -724,000.0
ROE -0.52% ROA -0.07%
Gross Margin 12.37% Operating Margin 0.37%
Net Margin -0.02% Free Cash Flow (TTM) 113.15M
ROIC 2.14% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.89 Current Ratio 1.74
Interest Coverage 0.93 Dividend Yield 0.00%
Valuation
P/E Ratio -4940.93 P/B Ratio 19.95
P/S Ratio 0.91 PEG Ratio 54.31
EV/EBITDA 226.23 Dividend Yield 0.00%
Market Cap 3.58B Enterprise Value 3.34B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 3.95B 2.70B 1.82B 1.43B 1.17B
Net Income -724,000.0 -128.04M -148.02M -149.55M -195.29M
EPS (Diluted) 0.00 -0.67 -0.79 -0.83 -1.14
Gross Profit 488.56M 296.69M 201.03M 184.28M 128.73M
Operating Income 14.75M -101.56M -127.82M -128.64M -178.07M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.07B 782.06M 591.88M 633.86M 630.90M
Total Liabilities 886.51M 681.11M 433.81M 394.56M 324.84M
Shareholders' Equity 179.28M 99.85M 156.95M 238.13M 306.04M
Total Debt 338.07M 329.26M 170.79M 164.60M 157.60M
Cash & Equivalents 577.94M 432.86M 202.90M 409.55M 466.60M
Current Assets 831.14M 661.64M 483.54M 544.55M 552.86M
Current Liabilities 476.53M 351.85M 263.02M 229.96M 167.25M

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#104 of 616
67

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026